Pressure BioSciences (PBI) has signed a contract services agreement with a top biotherapeutics company to enhance the process manufacturing of one of their candidate protein drugs.   Two of the major challenges associated with manufacturing recombinant proteins are the formation of aggregates, and protein misfolding. These are significant issues that can prevent a protein drug candidate from ever making it to market. PBI’s BaroFold technology platform addresses these manufacturing challenges.   ...